Domov › Nevroblastom › Pennsylvania
Klinične študije za Nevroblastom v Pennsylvania
14 študij za Nevroblastom išče udeležence na lokacijah v Pennsylvania.
Mesta v Pennsylvania
Uradno besedilo študije (angleško)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Children's Hospital of Philadelphia, Philadelphia
- in še 2
Vključevanje udeležencevFaza 3
Do 30 let · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
Vključevanje udeležencevFaza 1/2
6 Months – 25 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Vključevanje udeležencevFaza 2
Do 22 let · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Vključevanje udeležencevFaza 1/2
Do 26 let · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Vključevanje udeležencevFaza 1/2
Do 30 let · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06541262Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Vključevanje udeležencevFaza 2
Starost 1–21 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- in še 2
Vključevanje udeležencevFaza 3
365 Days – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Vključevanje udeležencevFaza 2
12 Months – 21 Years · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT05489887SPEARHEAD-3 Pediatric Study
- Children's Hospital of Philedephia, Philadelphia
Vključevanje udeležencevFaza 1/2
Starost 2–21 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05642455PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Children's Hospital of Philadelphia, Philadelphia
Vključevanje udeležencevFaza 1/2
Starost 1–30 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06721689NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Children's Hospital of Philadelphia, Philadelphia
Vključevanje udeležencevFaza 2
Starost 1–31 · Vsi spoli · Posodobljeno 20. jul. 2026 · NCT06450041Neuroblastoma Biology Study
- Children's Hospital of Philadelphia, Philadelphia
Vključevanje udeležencevOpazovalna študija
31 Days – 99 Years · Vsi spoli · Posodobljeno 23. mar. 2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Hospital of Philadelphia, Philadelphia
Vključevanje udeležencev
Do 17 let · Vsi spoli · Posodobljeno 10. feb. 2026 · NCT06831552Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.